Plasticell, a developer of stem cell technologies and therapies, is leading a consortium of pioneering gene therapy groups at UCL’s Institute of Child Health (ICH) and Great Ormond Street Hospital (GOSH) to develop advanced technologies for the manufacture of ex vivo gene therapies. The initial focus is on rare inherited disorders of the immune system including Chronic Granulomatous Disease.    “There are a number of highly promising gene therapy targets currently under investigation globally ...